Fennec Pharmaceuticals (FENC) Other Gross PP&E Adjustments (2022 - 2024)
Fennec Pharmaceuticals (FENC) has disclosed Other Gross PP&E Adjustments for 3 consecutive years, with -$38000.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 47.95% year-over-year to -$38000.0, compared with a TTM value of -$38000.0 through Sep 2025, up 47.95%, and an annual FY2024 reading of -$38000.0, up 47.95% over the prior year.
- Other Gross PP&E Adjustments was -$38000.0 for Q4 2024 at Fennec Pharmaceuticals, up from -$73000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$29000.0 in Q3 2023 and bottomed at -$77000.0 in Q4 2022.
- Average Other Gross PP&E Adjustments over 3 years is -$54250.0, with a median of -$55500.0 recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments grew 5.19% in 2023, then soared 47.95% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at -$77000.0 in 2022, then increased by 5.19% to -$73000.0 in 2023, then skyrocketed by 47.95% to -$38000.0 in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for FENC at -$38000.0 in Q4 2024, -$73000.0 in Q4 2023, and -$29000.0 in Q3 2023.